Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4341
-0.0109 (-2.45%)
At close: Mar 11, 2026, 4:00 PM EDT
0.4310
-0.0031 (-0.71%)
After-hours: Mar 11, 2026, 6:15 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $36.06 million as of March 11, 2026. Its market cap has decreased by -25.90% in one year.
Market Cap
36.06M
Enterprise Value
64.28M
1-Year Change
-25.90%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $36.06M, a decrease of -62.97%. That is a compound annual growth rate of -9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 36.96M | -63.51% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 40.08M |
| Veru Inc. | 39.64M |
| Palatin Technologies | 38.46M |
| Jasper Therapeutics | 38.34M |
| Sensei Biotherapeutics | 37.96M |
| Actinium Pharmaceuticals | 37.75M |
| PDS Biotechnology | 37.58M |
| ABVC BioPharma | 36.08M |